New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

MLA

Gallazzi, Marco, et al. “New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.” International Journal of Molecular Sciences, vol. 23, no. 14, July 2022. EBSCOhost, https://doi.org/10.3390/ijms23147542.

APA

Gallazzi, M., Ucciero, M. A. M., Faraci, D. G., Mahmoud, A. M., Al Essa, W., Gaidano, G., Mouhssine, S., & Crisà, E. (2022). New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes. International Journal of Molecular Sciences, 23(14). https://doi.org/10.3390/ijms23147542

Chicago

Gallazzi, Marco, Maghalie Anais Marie Ucciero, Danilo Giuseppe Faraci, Abdurraouf Mokhtar Mahmoud, Wael Al Essa, Gianluca Gaidano, Samir Mouhssine, and Elena Crisà. 2022. “New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.” International Journal of Molecular Sciences 23 (14). doi:10.3390/ijms23147542.